Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic NSCLC
Year: 2025
Type: dataset
Source: immuneACCESS
DOI: 10.21417/nm2025s
Authors: N Miller, N Miller, C Baik, J Neal, F Sun, A Houghton, V Nair, R Santana-Davila, S Lee, K Eaton, R Martins, C Rodriguez, H Wakelee, S Padda, E Konnick, S Chiou, D Tseng
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4406204299